Kore Nutrition Inc. (OTC: KORE.OB)s wholly owned subsidiary All in Energy has announced the establishment of their new Asian licensee All in Asia.
The Head of All in Asia is Mr. Desmond Liew, who is an experienced and highly capable marketing and distribution expert in Asia.
Through this license All IN Asia will manage the roll out of All IN Energy products throughout the important markets of Mainland China, Hong Kong, and Korea. Then it will expand its distribution over time throughout the remainder of Asia.
KORE has an initial price target of $10.50.
KOREs wholly-owned subsidiary, ALL IN Energy Drink, is a premium sugar free product, with no carbohydrates, and less than 10 calories per can.
ALL IN Energy uses herbs, vitamins and amino-acids to provide a balanced and sustained sharpening of focus and pure energy.
About Kore Nutrition and ALL IN
KORE, through its wholly-owned subsidiary, ALL IN, is engaged in the business of developing, producing, and selling non-alcoholic beverages. It has developed and is currently selling bottled water and four energy drinks. Its products are associated with professional poker and sports endurance events by the securing of endorsements of professional poker players, sponsoring poker tournaments, and by hosting ALL IN branded poker tournaments. Kore intends to expand the production, sales and distribution of ALL IN over the next twelve months. For additional information, visit ALL INs websites at www.allinenergy.com and www.allinenergy.net.
ARM Holdings (Nasdaq:ARMH) introduced the Cortex-A15 MPCore processor that delivers a 5x performance improvement over todays advanced smartphone processors, within a comparable energy footprint. In advanced infrastructure applications the Cortex-A15 processor running at up to 2.5GHz will enable highly scalable solutions within constantly shrinking energy, thermal and cost budgets. The Cortex-A15 processor is available for licensing today and is targeted at manufacture in 32nm, 28nm and future geometries.
As the latest addition to ARMHs Cortex-A family of processors, the Cortex-A15 MPCore processor will enable a new and vast array of products ranging from next-generation smartphones, tablets, large-screen mobile computing and high-end digital home entertainment devices through to wireless basestations and enterprise infrastructure products.
The Cortex-A15 also enjoys full application compatibility with all of the other highly acclaimed Cortex-A processors. This enables immediate access to an established developer and software ecosystem, including Android, Adobe Flash Player, Java Platform Standard Edition (Java SE), JavaFX, Linux, Microsoft Windows Embedded Compact 7, Symbian and Ubuntu, along with more than 700 ARM Connected Community members providing applications software, hardware and software development tools, middleware and SoC design services.
ARM designs the technology that lies at the heart of advanced digital products, from wireless, networking and consumer entertainment solutions to imaging, automotive, security and storage devices. ARMs comprehensive product offering includes 32-bit RISC microprocessors, graphics processors, video engines, enabling software, cell libraries, embedded memories, high-speed connectivity products, peripherals and development tools. Combined with comprehensive design services, training, support and maintenance, and the companys broad Partner community, they provide a total system solution that offers a fast, reliable path to market for leading electronics companies. Find out more about ARM by following these links:
ARM website: http://www.arm.com/
ARM Connected Community: http://www.arm.com/community/
ARM Blogs: http://blogs.arm.com/
ARMFlix on YouTube: http://www.youtube.com/user/ARMflix
ARM on Twitter:
Geron Corporation (Nasdaq:GERN) announced that Thomas B. Okarma, Ph.D., M.D., president and chief executive officer, will be presenting at three investor conferences during the month of September.
Rodman & Renshaw 12th Annual Healthcare Conference in New York City at 10:25 a.m. ET on Monday, September 13, 2010. The webcast link for the live audio and slide presentation will be available at the following website address: http://www.wsw.com/webcast/rrshq18/gern. The presentation will be archived for replay at the same address after the conference for a period of 30 days.
Stifel Nicolaus Healthcare Conference 2010 in Boston at 11:30 a.m. ET on Thursday, September 16, 2010.
UBS Global Life Sciences Conference in New York City at 10:30 a.m. ET on Wednesday, September 22, 2010. The webcast link for the live audio and slide presentation will be available in the Events section of Gerons website at: www.geron.com. The presentation will be archived for replay after the conference for a period of 30 days.
Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes. The company is advancing an anti-cancer drug and a cancer vaccine that target the enzyme telomerase through multiple clinical trials in different cancers. For more information, visit www.geron.com.
For FREE Daily Stock Alerts & Updates Signup At: http://pennytobuck.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyToBuck.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer ( http://pennytobuck.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyToBuck.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received seven thousand five hundred dollars from a third party (Alan Jones Group) for one (1) day of advertising for KORE Nutrition, Inc.(OTC BB: KORE.OB)
About the Author: